Hologic (NASDAQ:HOLX – Get Free Report) updated its third quarter 2024 earnings guidance on Friday. The company provided EPS guidance of 0.980-1.050 for the period, compared to the consensus EPS estimate of 1.020. The company issued revenue guidance of $992.5 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Hologic also updated its […]
Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 4.020-4.120 for the period, compared to the consensus earnings per share estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate […]
Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 4.020-4.120 for the period, compared to the consensus estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 […]
Hologic, Inc. (NASDAQ:HOLX – Free Report) – Investment analysts at William Blair lifted their FY2024 earnings per share estimates for Hologic in a report released on Friday, May 3rd. William Blair analyst A. Brackmann now anticipates that the medical equipment provider will earn $4.07 per share for the year, up from their prior estimate of […]
Hologic (NASDAQ:HOLX – Get Free Report) had its price objective increased by stock analysts at JPMorgan Chase & Co. from $85.00 to $91.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. JPMorgan Chase & Co.‘s price objective points to a […]